Changes and significance of serum levels of VEGF, ES, TKLK, TSP and sICAM-1 in patients with diabetic retinopathy
AIM: To investigate the changes of serum levels of vascular endothelial growth factor(VEGF), Endostatin(ES), thrombospondin(TSP), tissue kallikrein(TKLK)and soluble intercellular adhesion molecule-1(sICAM-1)in patients with diabetic retinopathy(DR)and its clinical significance. <p<METHODS: Sel...
Ausführliche Beschreibung
Autor*in: |
Li-Mei Hu [verfasserIn] Wu-Chao Yan [verfasserIn] Wei-Dong Ren [verfasserIn] Hui-Ying Liu [verfasserIn] Wen-Juan Deng [verfasserIn] Zheng-Rong Xu [verfasserIn] Li-Juan Zuo [verfasserIn] Jun Gu [verfasserIn] Li Shi [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2017 |
---|
Schlagwörter: |
vascular endothelial growth factor |
---|
Übergeordnetes Werk: |
In: Guoji Yanke Zazhi - Press of International Journal of Ophthalmology (IJO PRESS), 2017, 17(2017), 12, Seite 2304-2307 |
---|---|
Übergeordnetes Werk: |
volume:17 ; year:2017 ; number:12 ; pages:2304-2307 |
Links: |
Link aufrufen |
---|
DOI / URN: |
10.3980/j.issn.1672-5123.2017.12.28 |
---|
Katalog-ID: |
DOAJ020496869 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | DOAJ020496869 | ||
003 | DE-627 | ||
005 | 20230307035843.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230226s2017 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3980/j.issn.1672-5123.2017.12.28 |2 doi | |
035 | |a (DE-627)DOAJ020496869 | ||
035 | |a (DE-599)DOAJccfe68de8afd42b194390502b30d5a0a | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
050 | 0 | |a RE1-994 | |
100 | 0 | |a Li-Mei Hu |e verfasserin |4 aut | |
245 | 1 | 0 | |a Changes and significance of serum levels of VEGF, ES, TKLK, TSP and sICAM-1 in patients with diabetic retinopathy |
264 | 1 | |c 2017 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a AIM: To investigate the changes of serum levels of vascular endothelial growth factor(VEGF), Endostatin(ES), thrombospondin(TSP), tissue kallikrein(TKLK)and soluble intercellular adhesion molecule-1(sICAM-1)in patients with diabetic retinopathy(DR)and its clinical significance. <p<METHODS: Selected 60 patients with non-proliferative diabetic retinopathy(NPDR group), 60 patients with proliferative diabetic retinopathy(PDR group)were enrolled in this study. Sixty diabetic patients without diabetic retinopathy(DM group)and 60 healthy people(control group)were also enrolled. Collection time was from January 2014 to December 2016. Serum levels of VEGF, ES, TSP, TKLK and sICAM-1 were measured and compared. <p<RESULTS: The levels of serum VEGF, TKLK and sICAM-1 in PDR group were significantly higher than those in NPDR group, DM group and control group(<i<P</i<<0.05). The ES of PDR group was significantly lower than that of NPDR group, DM group and control group(<i<P</i<<0.05). The levels of VEGF, TKLK and ES in the NPDR group were significantly higher than those in the DM group and the control group(<i<P</i<<0.05). The serum VEGF in the NPDR group was positively correlated with the levels of ES, TKLK and sICAM-1(<i<P</i<<0.05). The serum VEGF of PDR group was positively related to the levels of TKLK and sICAM-1(<i<P</i<<0.05). There was no significant relationship between serum VEGF with ES and TSP in PDR group(<i<P</i<<0.05). <p<CONCLUSION: The levels of serum ES, TSP, TKLK and sICAM-1 in patients with DR have changed significantly, and the process of retinopathy has been affected by regulating the level of VEGF. | ||
650 | 4 | |a vascular endothelial growth factor | |
650 | 4 | |a endostatin | |
650 | 4 | |a platelet reactive protein | |
650 | 4 | |a tissue kallikrein | |
650 | 4 | |a soluble intercellular adhesion molecule -1 | |
650 | 4 | |a diabetic retinopathy | |
653 | 0 | |a Ophthalmology | |
700 | 0 | |a Wu-Chao Yan |e verfasserin |4 aut | |
700 | 0 | |a Wei-Dong Ren |e verfasserin |4 aut | |
700 | 0 | |a Hui-Ying Liu |e verfasserin |4 aut | |
700 | 0 | |a Wen-Juan Deng |e verfasserin |4 aut | |
700 | 0 | |a Zheng-Rong Xu |e verfasserin |4 aut | |
700 | 0 | |a Li-Juan Zuo |e verfasserin |4 aut | |
700 | 0 | |a Jun Gu |e verfasserin |4 aut | |
700 | 0 | |a Li Shi |e verfasserin |4 aut | |
773 | 0 | 8 | |i In |t Guoji Yanke Zazhi |d Press of International Journal of Ophthalmology (IJO PRESS), 2017 |g 17(2017), 12, Seite 2304-2307 |w (DE-627)1680946854 |x 16725123 |7 nnns |
773 | 1 | 8 | |g volume:17 |g year:2017 |g number:12 |g pages:2304-2307 |
856 | 4 | 0 | |u https://doi.org/10.3980/j.issn.1672-5123.2017.12.28 |z kostenfrei |
856 | 4 | 0 | |u https://doaj.org/article/ccfe68de8afd42b194390502b30d5a0a |z kostenfrei |
856 | 4 | 0 | |u http://ies.ijo.cn/cn_publish/2017/12/201712028.pdf |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/1672-5123 |y Journal toc |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/1672-5123 |y Journal toc |z kostenfrei |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_DOAJ | ||
912 | |a GBV_ILN_11 | ||
912 | |a GBV_ILN_2817 | ||
951 | |a AR | ||
952 | |d 17 |j 2017 |e 12 |h 2304-2307 |
author_variant |
l m h lmh w c y wcy w d r wdr h y l hyl w j d wjd z r x zrx l j z ljz j g jg l s ls |
---|---|
matchkey_str |
article:16725123:2017----::hneadinfcnefeulvlovgetltpnscmiptet |
hierarchy_sort_str |
2017 |
callnumber-subject-code |
RE |
publishDate |
2017 |
allfields |
10.3980/j.issn.1672-5123.2017.12.28 doi (DE-627)DOAJ020496869 (DE-599)DOAJccfe68de8afd42b194390502b30d5a0a DE-627 ger DE-627 rakwb eng RE1-994 Li-Mei Hu verfasserin aut Changes and significance of serum levels of VEGF, ES, TKLK, TSP and sICAM-1 in patients with diabetic retinopathy 2017 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier AIM: To investigate the changes of serum levels of vascular endothelial growth factor(VEGF), Endostatin(ES), thrombospondin(TSP), tissue kallikrein(TKLK)and soluble intercellular adhesion molecule-1(sICAM-1)in patients with diabetic retinopathy(DR)and its clinical significance. <p<METHODS: Selected 60 patients with non-proliferative diabetic retinopathy(NPDR group), 60 patients with proliferative diabetic retinopathy(PDR group)were enrolled in this study. Sixty diabetic patients without diabetic retinopathy(DM group)and 60 healthy people(control group)were also enrolled. Collection time was from January 2014 to December 2016. Serum levels of VEGF, ES, TSP, TKLK and sICAM-1 were measured and compared. <p<RESULTS: The levels of serum VEGF, TKLK and sICAM-1 in PDR group were significantly higher than those in NPDR group, DM group and control group(<i<P</i<<0.05). The ES of PDR group was significantly lower than that of NPDR group, DM group and control group(<i<P</i<<0.05). The levels of VEGF, TKLK and ES in the NPDR group were significantly higher than those in the DM group and the control group(<i<P</i<<0.05). The serum VEGF in the NPDR group was positively correlated with the levels of ES, TKLK and sICAM-1(<i<P</i<<0.05). The serum VEGF of PDR group was positively related to the levels of TKLK and sICAM-1(<i<P</i<<0.05). There was no significant relationship between serum VEGF with ES and TSP in PDR group(<i<P</i<<0.05). <p<CONCLUSION: The levels of serum ES, TSP, TKLK and sICAM-1 in patients with DR have changed significantly, and the process of retinopathy has been affected by regulating the level of VEGF. vascular endothelial growth factor endostatin platelet reactive protein tissue kallikrein soluble intercellular adhesion molecule -1 diabetic retinopathy Ophthalmology Wu-Chao Yan verfasserin aut Wei-Dong Ren verfasserin aut Hui-Ying Liu verfasserin aut Wen-Juan Deng verfasserin aut Zheng-Rong Xu verfasserin aut Li-Juan Zuo verfasserin aut Jun Gu verfasserin aut Li Shi verfasserin aut In Guoji Yanke Zazhi Press of International Journal of Ophthalmology (IJO PRESS), 2017 17(2017), 12, Seite 2304-2307 (DE-627)1680946854 16725123 nnns volume:17 year:2017 number:12 pages:2304-2307 https://doi.org/10.3980/j.issn.1672-5123.2017.12.28 kostenfrei https://doaj.org/article/ccfe68de8afd42b194390502b30d5a0a kostenfrei http://ies.ijo.cn/cn_publish/2017/12/201712028.pdf kostenfrei https://doaj.org/toc/1672-5123 Journal toc kostenfrei https://doaj.org/toc/1672-5123 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_11 GBV_ILN_2817 AR 17 2017 12 2304-2307 |
spelling |
10.3980/j.issn.1672-5123.2017.12.28 doi (DE-627)DOAJ020496869 (DE-599)DOAJccfe68de8afd42b194390502b30d5a0a DE-627 ger DE-627 rakwb eng RE1-994 Li-Mei Hu verfasserin aut Changes and significance of serum levels of VEGF, ES, TKLK, TSP and sICAM-1 in patients with diabetic retinopathy 2017 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier AIM: To investigate the changes of serum levels of vascular endothelial growth factor(VEGF), Endostatin(ES), thrombospondin(TSP), tissue kallikrein(TKLK)and soluble intercellular adhesion molecule-1(sICAM-1)in patients with diabetic retinopathy(DR)and its clinical significance. <p<METHODS: Selected 60 patients with non-proliferative diabetic retinopathy(NPDR group), 60 patients with proliferative diabetic retinopathy(PDR group)were enrolled in this study. Sixty diabetic patients without diabetic retinopathy(DM group)and 60 healthy people(control group)were also enrolled. Collection time was from January 2014 to December 2016. Serum levels of VEGF, ES, TSP, TKLK and sICAM-1 were measured and compared. <p<RESULTS: The levels of serum VEGF, TKLK and sICAM-1 in PDR group were significantly higher than those in NPDR group, DM group and control group(<i<P</i<<0.05). The ES of PDR group was significantly lower than that of NPDR group, DM group and control group(<i<P</i<<0.05). The levels of VEGF, TKLK and ES in the NPDR group were significantly higher than those in the DM group and the control group(<i<P</i<<0.05). The serum VEGF in the NPDR group was positively correlated with the levels of ES, TKLK and sICAM-1(<i<P</i<<0.05). The serum VEGF of PDR group was positively related to the levels of TKLK and sICAM-1(<i<P</i<<0.05). There was no significant relationship between serum VEGF with ES and TSP in PDR group(<i<P</i<<0.05). <p<CONCLUSION: The levels of serum ES, TSP, TKLK and sICAM-1 in patients with DR have changed significantly, and the process of retinopathy has been affected by regulating the level of VEGF. vascular endothelial growth factor endostatin platelet reactive protein tissue kallikrein soluble intercellular adhesion molecule -1 diabetic retinopathy Ophthalmology Wu-Chao Yan verfasserin aut Wei-Dong Ren verfasserin aut Hui-Ying Liu verfasserin aut Wen-Juan Deng verfasserin aut Zheng-Rong Xu verfasserin aut Li-Juan Zuo verfasserin aut Jun Gu verfasserin aut Li Shi verfasserin aut In Guoji Yanke Zazhi Press of International Journal of Ophthalmology (IJO PRESS), 2017 17(2017), 12, Seite 2304-2307 (DE-627)1680946854 16725123 nnns volume:17 year:2017 number:12 pages:2304-2307 https://doi.org/10.3980/j.issn.1672-5123.2017.12.28 kostenfrei https://doaj.org/article/ccfe68de8afd42b194390502b30d5a0a kostenfrei http://ies.ijo.cn/cn_publish/2017/12/201712028.pdf kostenfrei https://doaj.org/toc/1672-5123 Journal toc kostenfrei https://doaj.org/toc/1672-5123 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_11 GBV_ILN_2817 AR 17 2017 12 2304-2307 |
allfields_unstemmed |
10.3980/j.issn.1672-5123.2017.12.28 doi (DE-627)DOAJ020496869 (DE-599)DOAJccfe68de8afd42b194390502b30d5a0a DE-627 ger DE-627 rakwb eng RE1-994 Li-Mei Hu verfasserin aut Changes and significance of serum levels of VEGF, ES, TKLK, TSP and sICAM-1 in patients with diabetic retinopathy 2017 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier AIM: To investigate the changes of serum levels of vascular endothelial growth factor(VEGF), Endostatin(ES), thrombospondin(TSP), tissue kallikrein(TKLK)and soluble intercellular adhesion molecule-1(sICAM-1)in patients with diabetic retinopathy(DR)and its clinical significance. <p<METHODS: Selected 60 patients with non-proliferative diabetic retinopathy(NPDR group), 60 patients with proliferative diabetic retinopathy(PDR group)were enrolled in this study. Sixty diabetic patients without diabetic retinopathy(DM group)and 60 healthy people(control group)were also enrolled. Collection time was from January 2014 to December 2016. Serum levels of VEGF, ES, TSP, TKLK and sICAM-1 were measured and compared. <p<RESULTS: The levels of serum VEGF, TKLK and sICAM-1 in PDR group were significantly higher than those in NPDR group, DM group and control group(<i<P</i<<0.05). The ES of PDR group was significantly lower than that of NPDR group, DM group and control group(<i<P</i<<0.05). The levels of VEGF, TKLK and ES in the NPDR group were significantly higher than those in the DM group and the control group(<i<P</i<<0.05). The serum VEGF in the NPDR group was positively correlated with the levels of ES, TKLK and sICAM-1(<i<P</i<<0.05). The serum VEGF of PDR group was positively related to the levels of TKLK and sICAM-1(<i<P</i<<0.05). There was no significant relationship between serum VEGF with ES and TSP in PDR group(<i<P</i<<0.05). <p<CONCLUSION: The levels of serum ES, TSP, TKLK and sICAM-1 in patients with DR have changed significantly, and the process of retinopathy has been affected by regulating the level of VEGF. vascular endothelial growth factor endostatin platelet reactive protein tissue kallikrein soluble intercellular adhesion molecule -1 diabetic retinopathy Ophthalmology Wu-Chao Yan verfasserin aut Wei-Dong Ren verfasserin aut Hui-Ying Liu verfasserin aut Wen-Juan Deng verfasserin aut Zheng-Rong Xu verfasserin aut Li-Juan Zuo verfasserin aut Jun Gu verfasserin aut Li Shi verfasserin aut In Guoji Yanke Zazhi Press of International Journal of Ophthalmology (IJO PRESS), 2017 17(2017), 12, Seite 2304-2307 (DE-627)1680946854 16725123 nnns volume:17 year:2017 number:12 pages:2304-2307 https://doi.org/10.3980/j.issn.1672-5123.2017.12.28 kostenfrei https://doaj.org/article/ccfe68de8afd42b194390502b30d5a0a kostenfrei http://ies.ijo.cn/cn_publish/2017/12/201712028.pdf kostenfrei https://doaj.org/toc/1672-5123 Journal toc kostenfrei https://doaj.org/toc/1672-5123 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_11 GBV_ILN_2817 AR 17 2017 12 2304-2307 |
allfieldsGer |
10.3980/j.issn.1672-5123.2017.12.28 doi (DE-627)DOAJ020496869 (DE-599)DOAJccfe68de8afd42b194390502b30d5a0a DE-627 ger DE-627 rakwb eng RE1-994 Li-Mei Hu verfasserin aut Changes and significance of serum levels of VEGF, ES, TKLK, TSP and sICAM-1 in patients with diabetic retinopathy 2017 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier AIM: To investigate the changes of serum levels of vascular endothelial growth factor(VEGF), Endostatin(ES), thrombospondin(TSP), tissue kallikrein(TKLK)and soluble intercellular adhesion molecule-1(sICAM-1)in patients with diabetic retinopathy(DR)and its clinical significance. <p<METHODS: Selected 60 patients with non-proliferative diabetic retinopathy(NPDR group), 60 patients with proliferative diabetic retinopathy(PDR group)were enrolled in this study. Sixty diabetic patients without diabetic retinopathy(DM group)and 60 healthy people(control group)were also enrolled. Collection time was from January 2014 to December 2016. Serum levels of VEGF, ES, TSP, TKLK and sICAM-1 were measured and compared. <p<RESULTS: The levels of serum VEGF, TKLK and sICAM-1 in PDR group were significantly higher than those in NPDR group, DM group and control group(<i<P</i<<0.05). The ES of PDR group was significantly lower than that of NPDR group, DM group and control group(<i<P</i<<0.05). The levels of VEGF, TKLK and ES in the NPDR group were significantly higher than those in the DM group and the control group(<i<P</i<<0.05). The serum VEGF in the NPDR group was positively correlated with the levels of ES, TKLK and sICAM-1(<i<P</i<<0.05). The serum VEGF of PDR group was positively related to the levels of TKLK and sICAM-1(<i<P</i<<0.05). There was no significant relationship between serum VEGF with ES and TSP in PDR group(<i<P</i<<0.05). <p<CONCLUSION: The levels of serum ES, TSP, TKLK and sICAM-1 in patients with DR have changed significantly, and the process of retinopathy has been affected by regulating the level of VEGF. vascular endothelial growth factor endostatin platelet reactive protein tissue kallikrein soluble intercellular adhesion molecule -1 diabetic retinopathy Ophthalmology Wu-Chao Yan verfasserin aut Wei-Dong Ren verfasserin aut Hui-Ying Liu verfasserin aut Wen-Juan Deng verfasserin aut Zheng-Rong Xu verfasserin aut Li-Juan Zuo verfasserin aut Jun Gu verfasserin aut Li Shi verfasserin aut In Guoji Yanke Zazhi Press of International Journal of Ophthalmology (IJO PRESS), 2017 17(2017), 12, Seite 2304-2307 (DE-627)1680946854 16725123 nnns volume:17 year:2017 number:12 pages:2304-2307 https://doi.org/10.3980/j.issn.1672-5123.2017.12.28 kostenfrei https://doaj.org/article/ccfe68de8afd42b194390502b30d5a0a kostenfrei http://ies.ijo.cn/cn_publish/2017/12/201712028.pdf kostenfrei https://doaj.org/toc/1672-5123 Journal toc kostenfrei https://doaj.org/toc/1672-5123 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_11 GBV_ILN_2817 AR 17 2017 12 2304-2307 |
allfieldsSound |
10.3980/j.issn.1672-5123.2017.12.28 doi (DE-627)DOAJ020496869 (DE-599)DOAJccfe68de8afd42b194390502b30d5a0a DE-627 ger DE-627 rakwb eng RE1-994 Li-Mei Hu verfasserin aut Changes and significance of serum levels of VEGF, ES, TKLK, TSP and sICAM-1 in patients with diabetic retinopathy 2017 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier AIM: To investigate the changes of serum levels of vascular endothelial growth factor(VEGF), Endostatin(ES), thrombospondin(TSP), tissue kallikrein(TKLK)and soluble intercellular adhesion molecule-1(sICAM-1)in patients with diabetic retinopathy(DR)and its clinical significance. <p<METHODS: Selected 60 patients with non-proliferative diabetic retinopathy(NPDR group), 60 patients with proliferative diabetic retinopathy(PDR group)were enrolled in this study. Sixty diabetic patients without diabetic retinopathy(DM group)and 60 healthy people(control group)were also enrolled. Collection time was from January 2014 to December 2016. Serum levels of VEGF, ES, TSP, TKLK and sICAM-1 were measured and compared. <p<RESULTS: The levels of serum VEGF, TKLK and sICAM-1 in PDR group were significantly higher than those in NPDR group, DM group and control group(<i<P</i<<0.05). The ES of PDR group was significantly lower than that of NPDR group, DM group and control group(<i<P</i<<0.05). The levels of VEGF, TKLK and ES in the NPDR group were significantly higher than those in the DM group and the control group(<i<P</i<<0.05). The serum VEGF in the NPDR group was positively correlated with the levels of ES, TKLK and sICAM-1(<i<P</i<<0.05). The serum VEGF of PDR group was positively related to the levels of TKLK and sICAM-1(<i<P</i<<0.05). There was no significant relationship between serum VEGF with ES and TSP in PDR group(<i<P</i<<0.05). <p<CONCLUSION: The levels of serum ES, TSP, TKLK and sICAM-1 in patients with DR have changed significantly, and the process of retinopathy has been affected by regulating the level of VEGF. vascular endothelial growth factor endostatin platelet reactive protein tissue kallikrein soluble intercellular adhesion molecule -1 diabetic retinopathy Ophthalmology Wu-Chao Yan verfasserin aut Wei-Dong Ren verfasserin aut Hui-Ying Liu verfasserin aut Wen-Juan Deng verfasserin aut Zheng-Rong Xu verfasserin aut Li-Juan Zuo verfasserin aut Jun Gu verfasserin aut Li Shi verfasserin aut In Guoji Yanke Zazhi Press of International Journal of Ophthalmology (IJO PRESS), 2017 17(2017), 12, Seite 2304-2307 (DE-627)1680946854 16725123 nnns volume:17 year:2017 number:12 pages:2304-2307 https://doi.org/10.3980/j.issn.1672-5123.2017.12.28 kostenfrei https://doaj.org/article/ccfe68de8afd42b194390502b30d5a0a kostenfrei http://ies.ijo.cn/cn_publish/2017/12/201712028.pdf kostenfrei https://doaj.org/toc/1672-5123 Journal toc kostenfrei https://doaj.org/toc/1672-5123 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_11 GBV_ILN_2817 AR 17 2017 12 2304-2307 |
language |
English |
source |
In Guoji Yanke Zazhi 17(2017), 12, Seite 2304-2307 volume:17 year:2017 number:12 pages:2304-2307 |
sourceStr |
In Guoji Yanke Zazhi 17(2017), 12, Seite 2304-2307 volume:17 year:2017 number:12 pages:2304-2307 |
format_phy_str_mv |
Article |
institution |
findex.gbv.de |
topic_facet |
vascular endothelial growth factor endostatin platelet reactive protein tissue kallikrein soluble intercellular adhesion molecule -1 diabetic retinopathy Ophthalmology |
isfreeaccess_bool |
true |
container_title |
Guoji Yanke Zazhi |
authorswithroles_txt_mv |
Li-Mei Hu @@aut@@ Wu-Chao Yan @@aut@@ Wei-Dong Ren @@aut@@ Hui-Ying Liu @@aut@@ Wen-Juan Deng @@aut@@ Zheng-Rong Xu @@aut@@ Li-Juan Zuo @@aut@@ Jun Gu @@aut@@ Li Shi @@aut@@ |
publishDateDaySort_date |
2017-01-01T00:00:00Z |
hierarchy_top_id |
1680946854 |
id |
DOAJ020496869 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ020496869</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230307035843.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230226s2017 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.3980/j.issn.1672-5123.2017.12.28</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ020496869</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJccfe68de8afd42b194390502b30d5a0a</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RE1-994</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Li-Mei Hu</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Changes and significance of serum levels of VEGF, ES, TKLK, TSP and sICAM-1 in patients with diabetic retinopathy</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2017</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">AIM: To investigate the changes of serum levels of vascular endothelial growth factor(VEGF), Endostatin(ES), thrombospondin(TSP), tissue kallikrein(TKLK)and soluble intercellular adhesion molecule-1(sICAM-1)in patients with diabetic retinopathy(DR)and its clinical significance. <p<METHODS: Selected 60 patients with non-proliferative diabetic retinopathy(NPDR group), 60 patients with proliferative diabetic retinopathy(PDR group)were enrolled in this study. Sixty diabetic patients without diabetic retinopathy(DM group)and 60 healthy people(control group)were also enrolled. Collection time was from January 2014 to December 2016. Serum levels of VEGF, ES, TSP, TKLK and sICAM-1 were measured and compared. <p<RESULTS: The levels of serum VEGF, TKLK and sICAM-1 in PDR group were significantly higher than those in NPDR group, DM group and control group(<i<P</i<<0.05). The ES of PDR group was significantly lower than that of NPDR group, DM group and control group(<i<P</i<<0.05). The levels of VEGF, TKLK and ES in the NPDR group were significantly higher than those in the DM group and the control group(<i<P</i<<0.05). The serum VEGF in the NPDR group was positively correlated with the levels of ES, TKLK and sICAM-1(<i<P</i<<0.05). The serum VEGF of PDR group was positively related to the levels of TKLK and sICAM-1(<i<P</i<<0.05). There was no significant relationship between serum VEGF with ES and TSP in PDR group(<i<P</i<<0.05). <p<CONCLUSION: The levels of serum ES, TSP, TKLK and sICAM-1 in patients with DR have changed significantly, and the process of retinopathy has been affected by regulating the level of VEGF.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">vascular endothelial growth factor</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">endostatin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">platelet reactive protein</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">tissue kallikrein</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">soluble intercellular adhesion molecule -1</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">diabetic retinopathy</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Ophthalmology</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Wu-Chao Yan</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Wei-Dong Ren</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Hui-Ying Liu</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Wen-Juan Deng</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Zheng-Rong Xu</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Li-Juan Zuo</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Jun Gu</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Li Shi</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Guoji Yanke Zazhi</subfield><subfield code="d">Press of International Journal of Ophthalmology (IJO PRESS), 2017</subfield><subfield code="g">17(2017), 12, Seite 2304-2307</subfield><subfield code="w">(DE-627)1680946854</subfield><subfield code="x">16725123</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:17</subfield><subfield code="g">year:2017</subfield><subfield code="g">number:12</subfield><subfield code="g">pages:2304-2307</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.3980/j.issn.1672-5123.2017.12.28</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/ccfe68de8afd42b194390502b30d5a0a</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://ies.ijo.cn/cn_publish/2017/12/201712028.pdf</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1672-5123</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1672-5123</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_11</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2817</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">17</subfield><subfield code="j">2017</subfield><subfield code="e">12</subfield><subfield code="h">2304-2307</subfield></datafield></record></collection>
|
callnumber-first |
R - Medicine |
author |
Li-Mei Hu |
spellingShingle |
Li-Mei Hu misc RE1-994 misc vascular endothelial growth factor misc endostatin misc platelet reactive protein misc tissue kallikrein misc soluble intercellular adhesion molecule -1 misc diabetic retinopathy misc Ophthalmology Changes and significance of serum levels of VEGF, ES, TKLK, TSP and sICAM-1 in patients with diabetic retinopathy |
authorStr |
Li-Mei Hu |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)1680946854 |
format |
electronic Article |
delete_txt_mv |
keep |
author_role |
aut aut aut aut aut aut aut aut aut |
collection |
DOAJ |
remote_str |
true |
callnumber-label |
RE1-994 |
illustrated |
Not Illustrated |
issn |
16725123 |
topic_title |
RE1-994 Changes and significance of serum levels of VEGF, ES, TKLK, TSP and sICAM-1 in patients with diabetic retinopathy vascular endothelial growth factor endostatin platelet reactive protein tissue kallikrein soluble intercellular adhesion molecule -1 diabetic retinopathy |
topic |
misc RE1-994 misc vascular endothelial growth factor misc endostatin misc platelet reactive protein misc tissue kallikrein misc soluble intercellular adhesion molecule -1 misc diabetic retinopathy misc Ophthalmology |
topic_unstemmed |
misc RE1-994 misc vascular endothelial growth factor misc endostatin misc platelet reactive protein misc tissue kallikrein misc soluble intercellular adhesion molecule -1 misc diabetic retinopathy misc Ophthalmology |
topic_browse |
misc RE1-994 misc vascular endothelial growth factor misc endostatin misc platelet reactive protein misc tissue kallikrein misc soluble intercellular adhesion molecule -1 misc diabetic retinopathy misc Ophthalmology |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
cr |
hierarchy_parent_title |
Guoji Yanke Zazhi |
hierarchy_parent_id |
1680946854 |
hierarchy_top_title |
Guoji Yanke Zazhi |
isfreeaccess_txt |
true |
familylinks_str_mv |
(DE-627)1680946854 |
title |
Changes and significance of serum levels of VEGF, ES, TKLK, TSP and sICAM-1 in patients with diabetic retinopathy |
ctrlnum |
(DE-627)DOAJ020496869 (DE-599)DOAJccfe68de8afd42b194390502b30d5a0a |
title_full |
Changes and significance of serum levels of VEGF, ES, TKLK, TSP and sICAM-1 in patients with diabetic retinopathy |
author_sort |
Li-Mei Hu |
journal |
Guoji Yanke Zazhi |
journalStr |
Guoji Yanke Zazhi |
callnumber-first-code |
R |
lang_code |
eng |
isOA_bool |
true |
recordtype |
marc |
publishDateSort |
2017 |
contenttype_str_mv |
txt |
container_start_page |
2304 |
author_browse |
Li-Mei Hu Wu-Chao Yan Wei-Dong Ren Hui-Ying Liu Wen-Juan Deng Zheng-Rong Xu Li-Juan Zuo Jun Gu Li Shi |
container_volume |
17 |
class |
RE1-994 |
format_se |
Elektronische Aufsätze |
author-letter |
Li-Mei Hu |
doi_str_mv |
10.3980/j.issn.1672-5123.2017.12.28 |
author2-role |
verfasserin |
title_sort |
changes and significance of serum levels of vegf, es, tklk, tsp and sicam-1 in patients with diabetic retinopathy |
callnumber |
RE1-994 |
title_auth |
Changes and significance of serum levels of VEGF, ES, TKLK, TSP and sICAM-1 in patients with diabetic retinopathy |
abstract |
AIM: To investigate the changes of serum levels of vascular endothelial growth factor(VEGF), Endostatin(ES), thrombospondin(TSP), tissue kallikrein(TKLK)and soluble intercellular adhesion molecule-1(sICAM-1)in patients with diabetic retinopathy(DR)and its clinical significance. <p<METHODS: Selected 60 patients with non-proliferative diabetic retinopathy(NPDR group), 60 patients with proliferative diabetic retinopathy(PDR group)were enrolled in this study. Sixty diabetic patients without diabetic retinopathy(DM group)and 60 healthy people(control group)were also enrolled. Collection time was from January 2014 to December 2016. Serum levels of VEGF, ES, TSP, TKLK and sICAM-1 were measured and compared. <p<RESULTS: The levels of serum VEGF, TKLK and sICAM-1 in PDR group were significantly higher than those in NPDR group, DM group and control group(<i<P</i<<0.05). The ES of PDR group was significantly lower than that of NPDR group, DM group and control group(<i<P</i<<0.05). The levels of VEGF, TKLK and ES in the NPDR group were significantly higher than those in the DM group and the control group(<i<P</i<<0.05). The serum VEGF in the NPDR group was positively correlated with the levels of ES, TKLK and sICAM-1(<i<P</i<<0.05). The serum VEGF of PDR group was positively related to the levels of TKLK and sICAM-1(<i<P</i<<0.05). There was no significant relationship between serum VEGF with ES and TSP in PDR group(<i<P</i<<0.05). <p<CONCLUSION: The levels of serum ES, TSP, TKLK and sICAM-1 in patients with DR have changed significantly, and the process of retinopathy has been affected by regulating the level of VEGF. |
abstractGer |
AIM: To investigate the changes of serum levels of vascular endothelial growth factor(VEGF), Endostatin(ES), thrombospondin(TSP), tissue kallikrein(TKLK)and soluble intercellular adhesion molecule-1(sICAM-1)in patients with diabetic retinopathy(DR)and its clinical significance. <p<METHODS: Selected 60 patients with non-proliferative diabetic retinopathy(NPDR group), 60 patients with proliferative diabetic retinopathy(PDR group)were enrolled in this study. Sixty diabetic patients without diabetic retinopathy(DM group)and 60 healthy people(control group)were also enrolled. Collection time was from January 2014 to December 2016. Serum levels of VEGF, ES, TSP, TKLK and sICAM-1 were measured and compared. <p<RESULTS: The levels of serum VEGF, TKLK and sICAM-1 in PDR group were significantly higher than those in NPDR group, DM group and control group(<i<P</i<<0.05). The ES of PDR group was significantly lower than that of NPDR group, DM group and control group(<i<P</i<<0.05). The levels of VEGF, TKLK and ES in the NPDR group were significantly higher than those in the DM group and the control group(<i<P</i<<0.05). The serum VEGF in the NPDR group was positively correlated with the levels of ES, TKLK and sICAM-1(<i<P</i<<0.05). The serum VEGF of PDR group was positively related to the levels of TKLK and sICAM-1(<i<P</i<<0.05). There was no significant relationship between serum VEGF with ES and TSP in PDR group(<i<P</i<<0.05). <p<CONCLUSION: The levels of serum ES, TSP, TKLK and sICAM-1 in patients with DR have changed significantly, and the process of retinopathy has been affected by regulating the level of VEGF. |
abstract_unstemmed |
AIM: To investigate the changes of serum levels of vascular endothelial growth factor(VEGF), Endostatin(ES), thrombospondin(TSP), tissue kallikrein(TKLK)and soluble intercellular adhesion molecule-1(sICAM-1)in patients with diabetic retinopathy(DR)and its clinical significance. <p<METHODS: Selected 60 patients with non-proliferative diabetic retinopathy(NPDR group), 60 patients with proliferative diabetic retinopathy(PDR group)were enrolled in this study. Sixty diabetic patients without diabetic retinopathy(DM group)and 60 healthy people(control group)were also enrolled. Collection time was from January 2014 to December 2016. Serum levels of VEGF, ES, TSP, TKLK and sICAM-1 were measured and compared. <p<RESULTS: The levels of serum VEGF, TKLK and sICAM-1 in PDR group were significantly higher than those in NPDR group, DM group and control group(<i<P</i<<0.05). The ES of PDR group was significantly lower than that of NPDR group, DM group and control group(<i<P</i<<0.05). The levels of VEGF, TKLK and ES in the NPDR group were significantly higher than those in the DM group and the control group(<i<P</i<<0.05). The serum VEGF in the NPDR group was positively correlated with the levels of ES, TKLK and sICAM-1(<i<P</i<<0.05). The serum VEGF of PDR group was positively related to the levels of TKLK and sICAM-1(<i<P</i<<0.05). There was no significant relationship between serum VEGF with ES and TSP in PDR group(<i<P</i<<0.05). <p<CONCLUSION: The levels of serum ES, TSP, TKLK and sICAM-1 in patients with DR have changed significantly, and the process of retinopathy has been affected by regulating the level of VEGF. |
collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_11 GBV_ILN_2817 |
container_issue |
12 |
title_short |
Changes and significance of serum levels of VEGF, ES, TKLK, TSP and sICAM-1 in patients with diabetic retinopathy |
url |
https://doi.org/10.3980/j.issn.1672-5123.2017.12.28 https://doaj.org/article/ccfe68de8afd42b194390502b30d5a0a http://ies.ijo.cn/cn_publish/2017/12/201712028.pdf https://doaj.org/toc/1672-5123 |
remote_bool |
true |
author2 |
Wu-Chao Yan Wei-Dong Ren Hui-Ying Liu Wen-Juan Deng Zheng-Rong Xu Li-Juan Zuo Jun Gu Li Shi |
author2Str |
Wu-Chao Yan Wei-Dong Ren Hui-Ying Liu Wen-Juan Deng Zheng-Rong Xu Li-Juan Zuo Jun Gu Li Shi |
ppnlink |
1680946854 |
callnumber-subject |
RE - Ophthalmology |
mediatype_str_mv |
c |
isOA_txt |
true |
hochschulschrift_bool |
false |
doi_str |
10.3980/j.issn.1672-5123.2017.12.28 |
callnumber-a |
RE1-994 |
up_date |
2024-07-03T15:17:43.228Z |
_version_ |
1803571548105211904 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ020496869</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230307035843.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230226s2017 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.3980/j.issn.1672-5123.2017.12.28</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ020496869</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJccfe68de8afd42b194390502b30d5a0a</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RE1-994</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Li-Mei Hu</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Changes and significance of serum levels of VEGF, ES, TKLK, TSP and sICAM-1 in patients with diabetic retinopathy</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2017</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">AIM: To investigate the changes of serum levels of vascular endothelial growth factor(VEGF), Endostatin(ES), thrombospondin(TSP), tissue kallikrein(TKLK)and soluble intercellular adhesion molecule-1(sICAM-1)in patients with diabetic retinopathy(DR)and its clinical significance. <p<METHODS: Selected 60 patients with non-proliferative diabetic retinopathy(NPDR group), 60 patients with proliferative diabetic retinopathy(PDR group)were enrolled in this study. Sixty diabetic patients without diabetic retinopathy(DM group)and 60 healthy people(control group)were also enrolled. Collection time was from January 2014 to December 2016. Serum levels of VEGF, ES, TSP, TKLK and sICAM-1 were measured and compared. <p<RESULTS: The levels of serum VEGF, TKLK and sICAM-1 in PDR group were significantly higher than those in NPDR group, DM group and control group(<i<P</i<<0.05). The ES of PDR group was significantly lower than that of NPDR group, DM group and control group(<i<P</i<<0.05). The levels of VEGF, TKLK and ES in the NPDR group were significantly higher than those in the DM group and the control group(<i<P</i<<0.05). The serum VEGF in the NPDR group was positively correlated with the levels of ES, TKLK and sICAM-1(<i<P</i<<0.05). The serum VEGF of PDR group was positively related to the levels of TKLK and sICAM-1(<i<P</i<<0.05). There was no significant relationship between serum VEGF with ES and TSP in PDR group(<i<P</i<<0.05). <p<CONCLUSION: The levels of serum ES, TSP, TKLK and sICAM-1 in patients with DR have changed significantly, and the process of retinopathy has been affected by regulating the level of VEGF.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">vascular endothelial growth factor</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">endostatin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">platelet reactive protein</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">tissue kallikrein</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">soluble intercellular adhesion molecule -1</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">diabetic retinopathy</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Ophthalmology</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Wu-Chao Yan</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Wei-Dong Ren</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Hui-Ying Liu</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Wen-Juan Deng</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Zheng-Rong Xu</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Li-Juan Zuo</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Jun Gu</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Li Shi</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Guoji Yanke Zazhi</subfield><subfield code="d">Press of International Journal of Ophthalmology (IJO PRESS), 2017</subfield><subfield code="g">17(2017), 12, Seite 2304-2307</subfield><subfield code="w">(DE-627)1680946854</subfield><subfield code="x">16725123</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:17</subfield><subfield code="g">year:2017</subfield><subfield code="g">number:12</subfield><subfield code="g">pages:2304-2307</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.3980/j.issn.1672-5123.2017.12.28</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/ccfe68de8afd42b194390502b30d5a0a</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://ies.ijo.cn/cn_publish/2017/12/201712028.pdf</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1672-5123</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1672-5123</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_11</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2817</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">17</subfield><subfield code="j">2017</subfield><subfield code="e">12</subfield><subfield code="h">2304-2307</subfield></datafield></record></collection>
|
score |
7.4001417 |